|
[1]
|
中国肿瘤医院泌尿肿瘤协作组. 膀胱癌早诊早治专家共识(2024年版) [J]. 中国癌症杂志, 2024, 34(6): 607-618.
|
|
[2]
|
Dobruch, J. and Oszczudłowski, M. (2021) Bladder Cancer: Current Challenges and Future Directions. Medicina, 57, Article 749. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Richards, K.A., Ham, S., Cohn, J.A. and Steinberg, G.D. (2015) Urinary Tract Infection-Like Symptom Is Associated with Worse Bladder Cancer Outcomes in the Medicare Population: Implications for Sex Disparities. International Journal of Urology, 23, 42-47. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Ryk, C., Koskela, L.R., Thiel, T., Wiklund, N.P., Steineck, G., Schumacher, M.C., et al. (2015) Outcome after BCG Treatment for Urinary Bladder Cancer May Be Influenced by Polymorphisms in the NOS2 and NOS3 Genes. Redox Biology, 6, 272-277. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Patel, V.G., Oh, W.K. and Galsky, M.D. (2020) Treatment of Muscle-Invasive and Advanced Bladder Cancer in 2020. CA: A Cancer Journal for Clinicians, 70, 404-423. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lenis, A.T., Lec, P.M., Chamie, K. and MSHS, M. (2020) Bladder Cancer. JAMA, 324, 1980-1991. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Liu, W.M. and Zhang, X.A. (2006) KAI1/CD82, a Tumor Metastasis Suppressor. Cancer Letters, 240, 183-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Nihei, N., Ohta, S., Kuramochi, H., Kugoh, H., Oshimura, M., Barrett, J.C., et al. (1999) Metastasis Suppressor Gene(s) for Rat Prostate Cancer on the Long Arm of Human Chromosome 7. Genes, Chromosomes and Cancer, 24, 1-8. [Google Scholar] [CrossRef]
|
|
[9]
|
吕铮, 阎继东, 张志勇, 等. KAI1和Smad4在非小细胞肺癌的表达及临床病理意义[J]. 重庆医科大学学报, 2012, 37(11): 968-971.
|
|
[10]
|
季润元. 赵玉芳, 束晓明, 王娟, 林波, 冯振卿. 胃癌组织KAI1/CD82, MRP1/CD9 的表达及临床意义[J]. 江苏医药, 2012, 38(14): 1640-1642.
|
|
[11]
|
王洪鹏, 叶琳, 王驰, 谭毅, 陈鸿雁. KAI1基因对人鼻咽癌细胞株HNE-1增殖, 侵袭及转移能力的影响[J]. 肿瘤, 2010, 30(5): 386-390.
|
|
[12]
|
Ueda, T., Ichikawa, T., Tamaru, J., Mikata, A., Akakura, K., Akimoto, S., Imai, T., Yoshie, O., Shiraishi, T., Yatani, R., Ito, H. and Shimazaki, J. (1996) Expression of the KAI1 Protein in Benign Prostatic Hyperplasia and Prostate Cancer. The American Journal of Pathology, 149, 1435-1440.
|
|
[13]
|
艾星, 吴准, 唐滔, 等. KAI1/CD82和MRP-1/CD9在膀胱移行细胞癌中的表达及临床意义[J]. 中国现代医学杂志, 2008, 18(11): 1482-1485.
|
|
[14]
|
Wen, X., Fu, Y., Liu, H., Wu, J., Shao, X., Zhang, X., et al. (2015) Neuroprotection of Sevoflurane against Ischemia/reperfusion-Induced Brain Injury through Inhibiting JNK3/Caspase-3 by Enhancing Akt Signaling Pathway. Molecular Neurobiology, 53, 1661-1671. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zlobovskaya, O.A., Sergeeva, T.F., Shirmanova, M.V., Dudenkova, V.V., Sharonov, G.V., Zagaynova, E.V., et al. (2016) Genetically Encoded Far-Red Fluorescent Sensors for Caspase-3 Activity. BioTechniques, 60, 62-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bhat, A.A., Thapa, R., Afzal, O., Agrawal, N., Almalki, W.H., Kazmi, I., et al. (2023) The Pyroptotic Role of Caspase-3/GSDME Signalling Pathway among Various Cancer: A Review. International Journal of Biological Macromolecules, 242, Article ID: 124832. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liang, S., Mu, K., Wang, Y., Zhou, Z., Zhang, J., Sheng, Y., et al. (2013) CyclinD1, a Prominent Prognostic Marker for Endometrial Diseases. Diagnostic Pathology, 8, Article No. 138. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wang, H., Wang, H., Makki, M.S., Wen, J., Dai, Y., Shi, Q., Liu, Q., Zhou, X. and Wang, J. (2013) Overexpression of β-Catenin and CyclinD1 Predicts a Poor Prognosis in Ovarian Serous Carcinomas. International Journal of Clinical and Experimental Pathology, 7, 264-271.
|